Nutrient quality
Substantial boswellia, curcuminoids, bromelain, and quercetin offer broad inflammation support. Missing active percentages, enzyme activity, and absorption technology limit value confidence.
.| $ 120.99 | ||
Amazon | $ 102.90 | |
Vitacost | $ 120.99 |
Three capsules provide 600 mg total curcuminoids, 600 mg boswellia gum extract, 300 mg bromelain, and 300 mg quercetin. Every active has a substantial disclosed amount, making the formula much more focused than basic whole-herb combinations.
The combination covers inflammatory signaling, joint comfort, antioxidant activity, and enzyme-related support. Boswellia lacks a quantified total-acid or AKBA percentage, while bromelain lacks activity units and timing guidance.
The bottle provides 80 servings and requires three capsules each time. The large bottle lowers daily cost somewhat, but the serving remains expensive makes it better suited to buyers who value ingredient breadth more than low-cost single-ingredient supplementation.
Substantial boswellia, curcuminoids, bromelain, and quercetin offer broad inflammation support. Missing active percentages, enzyme activity, and absorption technology limit value confidence.
.Individual active weights are clearly disclosed. Some extract percentages, enzyme activity, or non-active label details remain incomplete.
.The supplied rating is favorable and the feedback base is adequate. No complaint-level evidence was supplied to assess recurring issues or purpose-specific experiences.
.The serving cost is high relative to the certainty provided by the label. Substantial ingredients help, but disclosure gaps weaken category competitiveness.
.Boswellia,
Missing active-standardization details make actual potency harder to verify. Bromelain activity units and an absorption system for the botanical extracts would materially strengthen confidence.
Boswellia, curcuminoids, bromelain, and quercetin create broad support for inflammation-related joint comfort. The formula does not provide cartilage building blocks or a direct lubrication ingredient.
The ingredient amounts are substantial, but boswellic-acid standardization and bromelain enzyme activity are not disclosed. Boswellia, curcumin, and bromelain may increase bleeding tendency with anticoagulant or antiplatelet medicines.
| Ingredient | Amount per serving |
|---|---|
Boswellia serrata gum extract (Alpha Boswellic Acid, Beta Boswellic Acid) | 600 mg |
Bromelain | 300 mg |
Curcuma longa rhizome extract (Total Curcuminoids) | 600 mg |
Quercetin Dihydrate | 300 mg |
The blend provides a meaningful amount of bromelain alongside boswellia, curcuminoids, and quercetin for broad inflammation-support use. Enzyme activity is not disclosed, so bromelain potency and consistency remain uncertain. The standard capsule and missing timing guidance also limit confidence in delivery for systemic use.
The label reports a substantial Boswellia extract amount, but it does not state the concentration of total boswellic acids or AKBA. No absorption enhancer or advanced delivery system is identified, which leaves bioavailability uncertain. Bromelain and turmeric may increase bleeding risk with anticoagulant or antiplatelet medicines, and the high cost is difficult to justify without clearer standardization.
The disclosed curcuminoid amount falls within a useful potency range, but the label does not identify a standardization percentage or absorption technology. Its multi-ingredient approach includes boswellia, bromelain, and quercetin, although those additions do not resolve the turmeric delivery gap. The high serving cost is difficult to justify for turmeric when active-form quality and bioavailability remain unclear.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.